Inclusion Criteria
Patients were included in the analysis if they met all
of the following inclusion criteria:
• Their information was in the PharMetrics Integrated
Database between July 2008 and June 2010
• They had a follow-up period of 12 months after AF
diagnosis
• They were aged ≥18 years
• They had ≥1 primary or secondary diagnoses of AF
• Their pharmacy and medical claims were both record-
ed in the database.